Last edition
News about Global Pharma
PerkinElmer to acquire Nexcelom Bioscience for US$ 260 million
Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for-purpose cell counting method selection and development instructions that follow ISO Cell Counting Standards and aid in the development of cell and gene and immuno-oncology therapies
Global Pharma | 14/05/2021 | By Darshana | 282
Lilly gives out licences for Covid-19 drug Baricitinib to Dr Reddy's, MSN Labs and Torrent Pharmac
Eli Lilly and Company announced that it has issued additional royalty-free, non-exclusive voluntary licenses to established Indian pharma manufacturers of generic medicines, Dr Reddy's, MSN Laboratories and Torrent Pharmaceuticals, who will be collaborating with Lilly to accelerate and expand the availability of baricitinib in India
Global Pharma | 13/05/2021 | By Darshana | 622
Biogen and Capsigen announced that they have entered into a strategic research collaboration, Capsigen's proprietary TRADE platform and associated technologies will be utilized with the aim to create and identify novel AAV capsids tailored to meet disease-specific transduction profiles.
Global Pharma | 12/05/2021 | By Hemant | 496
Dr Reddy's Lab launches Avigan for COVID-19 treatment
Dr Reddy's Laboratories Ltd announced the launch of Avigan (favipiravir) 200 mg tablets in India for the treatment of patients with mild to moderate COVID-19 disease
Global Pharma | 19/08/2020 | By Darshana | 746
Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore
Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020
Global Pharma | 13/08/2020 | By Darshana | 396
FDA Posts Interim Results from Required Essure Postmarket Surveillance Study
Although Essure is no longer available for implantation in the U.S., the FDA remains committed to evaluating long-term safety information in women who have received the device, including data from an FDA-required postmarket surveillance study.
Global Pharma | 10/07/2020 | By Darshana | 450
Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements
Global Pharma | 15/05/2020 | By Darshana | 453
Merck's foundational CRISPR-Cas9 technology receives US patnet
Merck, a leading science and technology company, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States
Global Pharma | 12/05/2020 | By Darshana | 513
The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic
Global Pharma | 10/05/2020 | By Darshana | 357
FDA Continues to Combat Fraudulent COVID-19 Medical Products
Today, the U.S. Food and Drug Administration is providing an update on the agency's efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic
Global Pharma | 08/05/2020 | By Darshana | 417
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy